| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/06/2008 | US20080058412 1-(4-((R,S)-5-[1,2]dithiolan-3-ylpentyloxy)-3,5-dimethylphenyl)-3-(4-carboxydimethylmethyloxy-3,5-dimethylphenyl)prop-2-en-1-one; peroxisome proliferator activated receptor agonist; lipid or glucose metabolism: hyperlipidemia, diabetes, obesity; dermatologicalal: psoriasis, atopic dermatitis, acne |
| 03/06/2008 | US20080058411 Methods For Treating Resistant Or Refractory Tumors |
| 03/06/2008 | US20080058410 Composition for Stabilizing Vitamin C in Water Phase and Method for Stabilizing C Using Thereof |
| 03/06/2008 | US20080058409 Esterified Catechins, Processes for Producing the Same, and Foods and Beverages as well as Cosmetics Containing Such Esterified Catechins |
| 03/06/2008 | US20080058408 Low-dose doxepin for treatment of sleep disorders in elderly patients |
| 03/06/2008 | US20080058407 Methods of improving the pharmacokinetics of doxepin |
| 03/06/2008 | US20080058406 Lipoic acid derivatives |
| 03/06/2008 | US20080058405 Replicating melatonin signaling in a fetus, newborn or suckling infant |
| 03/06/2008 | US20080058404 Co-milling ramipril with lubricant selected from glyceryl behenate, polyethylene glycol, stearic acid, sodium stearyl fumarate, and combinations thereof; cardiovascular disorders; hypertension |
| 03/06/2008 | US20080058403 Administering photoactive porphyrin, and awaiting localization in ocular tissue; radiating with laser light; macular degeneration; neovascularization |
| 03/06/2008 | US20080058402 3-(1H-indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-(N-phenoxycarboxamide); anticancer agents; protein kinase inhibitors |
| 03/06/2008 | US20080058401 1-(2-(3,3-dimethylbutyl)-4-(trifluoromethyl)benzyl)-3-(1-methyl-1H-indazol-4-yl)urea; transient receptor potential vanilloid-1 (TRPV1) antagonist; low inhibitory activity against drug metabolism enzyme CYP3A4; antinociceptive, analgesic, antiinflammatory, antischemic agent; neuropatic pain |
| 03/06/2008 | US20080058400 Skin external preparation |
| 03/06/2008 | US20080058399 Candesartan or candesartan cilexetil; improved bioavailability |
| 03/06/2008 | US20080058398 1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-(3-{[4-methyl-5-(4-methyl-1,3-oxazol-5-yl)-4H-1,2,4-triazol-3-yl]thio}propyl)-3-azabicyclo[3.1.0]hexane tartrate; antipsychotic agents; nuclear magnetic resonance |
| 03/06/2008 | US20080058397 Therapeutic substituted hydantoins and related compounds |
| 03/06/2008 | US20080058396 Administering bryostatins as activators and Protein Kinase C, for stimulation of dendritic spine density |
| 03/06/2008 | US20080058395 Fused heterocyclic inhibitors of D-amino acid oxidase |
| 03/06/2008 | US20080058392 Prostaglandin derivatives |
| 03/06/2008 | US20080058391 Novel compounds |
| 03/06/2008 | US20080058388 Administering rosiglitazone and/or salts, and glimepiride to mammals for prophylaxis of non-insulin dependent diabetes; metabolic disorders; hypoglycemic agents |
| 03/06/2008 | US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 03/06/2008 | US20080058386 1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-ylamine; inhibiting tubulin polymerization; anticarcinogenic; mitotic arrest of microtubule structure, neovascularization; angiogenesis inhibitor: atherosclerosis, rheumatoid arthritis or Crohn's disease, diabetic retinopathy, psoriasis |
| 03/06/2008 | US20080058385 For treatment of Type II diabetes, obesity |
| 03/06/2008 | US20080058384 Novel Compounds |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058382 Polyamine compounds |
| 03/06/2008 | US20080058381 Such as 1-[bis(4-chlorophenyl)methyl]-3-[(3,5-difluorophenyl)(methylsulfonyl)methylene]azetidine |
| 03/06/2008 | US20080058380 2-{[2-(3,5-difluorophenyl)acetyl]amino}-N-{5-[2-(isopropoxymethyl)phenyl]-1,3-thiazol-2-yl}propanamide; neuroprotectant; neurodegenerative diseases: Alzheimer's and Parkinson's disease, Down syndrome, amyloid angiopathy and cerebrovascular disorders |
| 03/06/2008 | US20080058379 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 03/06/2008 | US20080058378 Compounds which have activity at M1 receptor and their uses in medicine. |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058376 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels; neuropathic pain |
| 03/06/2008 | US20080058375 Bone disorders; osteoporosis; antihistamines; sexual disorders; antiinflammatory agents; antiarthritic agents; vision defects; antiulcer agents |
| 03/06/2008 | US20080058374 Biphenyl-2-ylcarbamic acid 1-[2-({3-[2-(4-hydroxybenzylamino)ethylcarbamoyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; drug delivery; pulmonary disorders |
| 03/06/2008 | US20080058373 Compositions and Methods for Treating or Preventing Glaucoma or Progression Thereof |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058371 Bactericides; produces little or no tissue damage or irritation at the injection site |
| 03/06/2008 | US20080058370 For treating obesity, metabolic syndrome, diabetes, hepatic lipidosis or nonalcoholic fatty liver disease; kits |
| 03/06/2008 | US20080058369 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 03/06/2008 | US20080058368 4,5,6,7-Tetrahydro-[1,2]Dithiolo[4,3-C] Pyridine-3-Thione Compounds |
| 03/06/2008 | US20080058367 Process for the purification of palonosetron or its salt |
| 03/06/2008 | US20080058366 Rhinitis Treatment Regimens |
| 03/06/2008 | US20080058365 Fused heterocyclic compounds |
| 03/06/2008 | US20080058364 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
| 03/06/2008 | US20080058363 Pharmaceutical composition for treating fecal incontinence and anal itch |
| 03/06/2008 | US20080058362 Nontoxic N-methyl-D-aspartate receptor antagonist such as dextromethorphan, dextrorphan, ketamine; sustained release |
| 03/06/2008 | US20080058361 Tetrahydrobenzfluorene derivatives |
| 03/06/2008 | US20080058360 Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058358 Anticancer/antitumor agents; S-(4-([4-([(1R,2R)-2-Hydroxy-1-methylpropyl]amino)-5-(trifluoromethyl)-pyrimidin-2-yl]amino)phenyl)-S-methyl-N-[(trifluoromethyl)sulphonyl]-sulphimide for example |
| 03/06/2008 | US20080058357 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/06/2008 | US20080058356 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| 03/06/2008 | US20080058355 Anticancer agents |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058353 Using 3-(7-(2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3triazolo(4,5)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane( 1 ,2-diol |
| 03/06/2008 | US20080058351 Novel heterobicyclic compounds |
| 03/06/2008 | US20080058350 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | US20080058349 Cognitive impairment, Alzheimer's Disease, neurodegeneration and dementia; Beta site APP Cleaving Enzyme (BACE) inhibitors; beta-secretase inhibitors; 3,3-Difluoro-8-(2',6-difluoro-3'-methoxybiphenyl-3-yl)-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine acetate for example |
| 03/06/2008 | US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate |
| 03/06/2008 | US20080058347 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | US20080058346 Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof |
| 03/06/2008 | US20080058345 Combination Therapy with Mecamylamine for the Treatment of Mood Disorders |
| 03/06/2008 | US20080058344 Enantiomers of 2'-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics |
| 03/06/2008 | US20080058343 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 03/06/2008 | US20080058342 potent kinase insert domain-containing receptor (KDR) inhibitors with improved selectivity and pharmacokinetics; VEGF (vascular endothelial growth factor) inhibitors; cancer and rheumatoid arthritis; e.g. 7-(2-[4-(acetylmethyl)piperazin-1-yl]ethoxy)-6-methoxy-4-[(2-methyl-1H-indol-5-yl)oxy]quinazoline |
| 03/06/2008 | US20080058341 Azaindazole compounds and methods of use |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058339 4-phenyl-3-substituted pyridazine compounds such as tert-Butyl 4-[((6-[4-(methylsulfonyl)phenyl]pyridazin-3-yl)oxy)methyl]-piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; diabetes and obesity; use with a dipeptidyl peptidase IV (DPP IV) inhibitor |
| 03/06/2008 | US20080058338 Stable Solid Dosage Forms of Aminopterin |
| 03/06/2008 | US20080058337 Pyrrolotriazine kinase inhibitors |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
| 03/06/2008 | US20080058330 Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof |
| 03/06/2008 | US20080058329 Novel indane compounds |
| 03/06/2008 | US20080058328 Substituted 4-phenyltetrahydroisoquinolines, pharmaceuitcal compositions comprising them and therapeutic methods for their use |
| 03/06/2008 | US20080058327 4-piperazinyl-5H-6,7-dihydrocyclopenta(d)pyrimidines; Hyperproliferative diseases such as cancer |
| 03/06/2008 | US20080058326 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058324 Alpha-Keto Carbonyl Calpain Inhibitors |
| 03/06/2008 | US20080058323 Therapy of vascular system diseases |
| 03/06/2008 | US20080058322 Small molecule inhibitors targeted at Bcl-2 |
| 03/06/2008 | US20080058321 Benzothiazin-3-one compound and intermediate therefor |
| 03/06/2008 | US20080058320 Organic Compounds |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/06/2008 | US20080058318 Administering high dosage |
| 03/06/2008 | US20080058317 Administering high dosage |
| 03/06/2008 | US20080058316 Cancer treatment with gama-secretase inhibitors |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080058313 Tetrahydro-2h-indazole pyrazole cannabinoid modulators |
| 03/06/2008 | US20080058312 Modulators of hepatocyte growth factor/c-Met activity |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058310 High-density lipoprotein-cholesterol level elevating agent |
| 03/06/2008 | US20080058309 Quinoline-5-carboxamides or thioamides; P2X7 purinergic receptor antagonists; treating rheumatoid arthritis, osteoarthritis, asthma, chronic obstructive pulmonary disease, or inflammatory bowel disease; N-[6-Chloro-2-[(3R)-3-hydroxy-1-pyrrolidinyl]-5-quinolinyl]-2-(phenylamino)-acetamide for example |
| 03/06/2008 | US20080058308 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants |